Outpatient Surgery Magazine

Special Edition: 2021 Big Book of Surgery - Subscribe to Outpatient Surgery Magazine

Outpatient Surgery Magazine, providing current information on Surgical Services, Surgical Facility Administration, Outpatient Surgery News and Trends, OR Excellence and more.

Issue link: http://outpatientsurgery.uberflip.com/i/1316515

Contents of this Issue

Navigation

Page 33 of 59

34 • S U P P L E M E N T T O O U T P A T I E N T S U R G E R Y M A G A Z I N E • D E C E M B E R 2 0 2 0 SPECIAL ADVERTISING SUPPLEMENT Make Preparing Quad Tendon Grafts Simpler, Faster Arthrex's FiberTag TightRope implant makes it easier and simpler to attach single-ended grafts, such as quad tendon grafts, to the ACL TightRope RT and ABS implants. The FiberTag TightRope simplifies graft prep and handling with an integrated card and clamp. The FiberTag suture is passed through the graft and FiberTag reinforcement; then the FiberTag TightRope firmly attaches the graft to the ACL TightRope. That means a strong, consistent connection between the suture and TightRope loop. The system includes a specially designed GraftClamp Graft Prep instrument to hold the graft and FiberTag system. For more information, visit www.Arthrex.com O R T H O P E D I C S Do Your Cataract Patients Hate Drops? Make post-op compliance for cataract patients easier with Dexycu, an innovative FDA-approved steroid medication intended for injection into the posterior chamber after surgery. Dexycu contains extended release dexamethasone, which releases slowly into the ocular tissues over time, making patients much less likely to have to use drops. In a randomized, double-masked, placebo-controlled trial comparing Dexycu to vehicle, the Dexycu patients were much less likely to require additional topical medication. Dexycu kits come with a vial and a sterile syringe for withdrawing the drug and a bent cannula for injection. For more information, call (617) 926-5000 or visit www.eyepointpharma.com You Can Be Confident in These Ophthalmology and Urology Medications EDGE Pharma is a pharmaceutical sterile and non-sterile 503B Outsourcing Facility offering high quality innovative solutions for the healthcare community. Available ophthalmic medications include hyaluronidase ophthalmic blocks (bupivacaine/lido- caine/hyaluronidase and epinephrine/lidocaine/hyaluronidase) in premixed, ready-to-administer retrobulbar and peribulbar ophthalmic blocks dispensed in unit-dose syringes; povidone iodine, mitomycin ophthalmic and EDTA; and epi-shugarcaine dilating injections in unit-dose syringes. EDGE Pharma also offers these urology medications in ready-to-administer kits, prefilled unit-dose Luer Lock syringes with the CSTD pre- attached: the new gemcitabine bladder instillation kit (1 g/50 mL) and the mitomycin bladder instillation kit (40 mg/40 mL). For more information, call (802) 992-1178 or visit www.edgepharma

Articles in this issue

Links on this page

Archives of this issue

view archives of Outpatient Surgery Magazine - Special Edition: 2021 Big Book of Surgery - Subscribe to Outpatient Surgery Magazine